<SEC-DOCUMENT>0001193125-20-255111-index.html : 20200928
<SEC-HEADER>0001193125-20-255111.hdr.sgml : 20200928
<ACCEPTANCE-DATETIME>20200928061128
ACCESSION NUMBER:		0001193125-20-255111
CONFORMED SUBMISSION TYPE:	8-A12B
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20200928
DATE AS OF CHANGE:		20200928

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			C4 Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001662579
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				475617627
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-A12B
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39567
		FILM NUMBER:		201201931

	BUSINESS ADDRESS:	
		STREET 1:		675 WEST KENDALL STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		(202) 421-7994

	MAIL ADDRESS:	
		STREET 1:		675 WEST KENDALL STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-A12B
<SEQUENCE>1
<FILENAME>d74674d8a12b.htm
<DESCRIPTION>8-A12B
<TEXT>
Document 1 - file: d74674d8a12b.htm

</DOCUMENT>
</SEC-DOCUMENT>